Autor(es)Van Koningsveld R,Van Doorn P A,Schmitz P I,Van der Meché F G

ResumoThe authors assessed the referral pattern and outcome in patients with Guillain-Barré syndrome (n = 266) after the introduction of intravenous immunoglobulin (IVIg). Fewer patients were transferred from small to large hospitals after the introduction of IVIg (p = 0.05). This did not result in a worse outcome in patients treated in small centers. The introduction of IVIg has led to a better use of different levels of health care facilities.

ImprentaNeurology, v. 56, n. 4, p. 564-566, 2001

DescritoresGuillain-Barre Syndrome - Proteins ; Guillain-Barre Syndrome - Antibodies ; Guillain-Barre Syndrome - Epidemiology

Data de Publicação:2001